Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/202079
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Aguirre, Josu | - |
dc.contributor.author | Padilla, Natàlia | - |
dc.contributor.author | Özkan, Selen | - |
dc.contributor.author | Riera, Casandra | - |
dc.contributor.author | Feliubadaló, Lídia | - |
dc.contributor.author | Cruz, Xavier de la | - |
dc.date.accessioned | 2023-09-21T12:27:13Z | - |
dc.date.available | 2023-09-21T12:27:13Z | - |
dc.date.issued | 2023-07-24 | - |
dc.identifier.issn | 1422-0067 | - |
dc.identifier.uri | http://hdl.handle.net/2445/202079 | - |
dc.description.abstract | Pathogenicity predictors are computational tools that classify genetic variants as benign or pathogenic; this is currently a major challenge in genomic medicine. With more than fifty such predictors available, selecting the most suitable tool for clinical applications like genetic screening, molecular diagnostics, and companion diagnostics has become increasingly challenging. To address this issue, we have developed a cost-based framework that naturally considers the various components of the problem. This framework encodes clinical scenarios using a minimal set of parameters and treats pathogenicity predictors as rejection classifiers, a common practice in clinical applications where low-confidence predictions are routinely rejected. We illustrate our approach in four examples where we compare different numbers of pathogenicity predictors for missense variants. Our results show that no single predictor is optimal for all clinical scenarios and that considering rejection yields a different perspective on classifiers. | - |
dc.format.extent | 22 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI AG | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/ijms241411872 | - |
dc.relation.ispartof | International Journal of Molecular Sciences, 2023, vol. 24, num. 14 | - |
dc.relation.uri | https://doi.org/10.3390/ijms241411872 | - |
dc.rights | cc by (c) Aguirre, Josu et al., 2023 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
dc.subject.classification | Diagnòstic molecular | - |
dc.subject.classification | Medicina personalitzada | - |
dc.subject.classification | Economia de la salut | - |
dc.subject.other | Molecular diagnosis | - |
dc.subject.other | Personalized medicine | - |
dc.subject.other | Medical economics | - |
dc.title | Choosing Variant Interpretation Tools for Clinical Applications: Context Matters | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.date.updated | 2023-08-22T11:19:23Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 37511631 | - |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ijms-24-11872.pdf | 2.44 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License